JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 16 No. 6 478-482
© 1975 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hambright, P.
Right arrow Articles by Shipley, B. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hambright, P.
Right arrow Articles by Shipley, B. A.

Chemistry of Technetium Radiopharmaceuticals. I. Exploration of the Tissue Distribution and Oxidation State Consequences of Technetium (IV) in Tc-Sn-Gluconate and Tc-Sn-EHDP Using Carrier 99Tc

Peter Hambright, James McRae, Peter E. Valk, Alan J. Bearden and Barbara A. Shipley

Donner Laboratory, Lawrence Berkeley Laboratory, University of California, Berkeley, California
Howard University, Washington, D.C.

Correspondence: For reprints contact: J. McRae or P. Hambright, Donner Laboratory, University of California, Berkeley, Calif. 94720.

ABSTRACT

The distribution in rats of the renal agent Tc-Sn-gluconate using both 99mTc and carrier amounts of 99Tc was similar. The same behavior was shown with the bone agent Tc-Sn-EHDP. The radiopharmaceutical consequences of the observed Tc(IV) oxidation state in these systems are explored.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1975 by the Society of Nuclear Medicine.